Skip to content

Randomized controlled trial on the efficacy of the prolonged exposure therapy for PTSD

Randomized controlled trial on the efficacy of the prolonged exposure therapy for PTSD - RCT of the PE for PTSD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000001183
Enrollment
40
Registered
2008-06-11
Start date
2008-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posttraumatic Stress Disorder (PTSD)

Interventions

The prolonged exposure therapy added to the treatment as usual treatment as usual

Sponsors

National Institute of Mental Health, National Center of Neurology and Psychiatry
Lead Sponsor
Institute of Women&#39
Collaborator
s Health, Tokyo Women&#39
Collaborator
s Medical University
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Diagnosed as PTSD by the CAPS with its score greater than 40 2.More than 6 months duration of PTSD 3.PTSD was caused by human violence, such as rape, intimate partner violence, assault etc. 4.Traumatized after the age 15 5.Those who live in the catchment area of the participating centers 6.Those who can spend two hours a day for the homework 7.Native Japanese speaker

Exclusion criteria

Exclusion criteria: 1.Comorbidity of schizophrenia, bipolar disorder, alcohol or drug dependence, group A personality disorder. 2.Presence of psychopathology that needs acute treatment, such as severe depression, self-harm, severe suicidal attempt, etc. 3.Physical disease that may interfere psychological treatment 4.Those who have a history of epilepsy and whose EEG has not been normalized 5.Pregnant 6.Those who have difficulty in understanding the procedure of the study or treatment protocol, due to illiteracy or intellectual problem, etc. 7.Those who have already received psychological treatment based on exposure to trauma, including EMDR 8.Ongoing or scheduled court litigation for which PTSD works favorably (excluding arbitration or litigation for divorce) 9.Suicidal attempts of serious self harm within past six months(self mutilation that needs suture, overdose of drugs that caused loss of consciousness, manipulative self-harm in order to threat others, etc.) 10.Those who are participating in other clinical trial 11.Those who are judged by the screening doctors as inadequate, due to disturbed consciousness, poor treatment compliance, unstable family environment such as ongoing trauma, etc.

Design outcomes

Primary

MeasureTime frame
The severity of PTSD symptoms measured by the CAPS

Secondary

MeasureTime frame
1.PTSD diagnosis confirmed by the CAPS 2.Psychological symptoms other than PTSD, i.e., STAI, SCL-90R, DES, PTCI, WHOQOL 3.Autonomic nervous function at rest 4.Serum cortisol and stress related hormones

Countries

Japan

Contacts

Public ContactYoshiharu Kim

National Institute of Mental Health, National Center of Neurology and Psychiatry Department of Adult Mental Health

042-346-1985

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026